CervoMed
CRVO
12 hedge funds and large institutions have $2.48M invested in CervoMed in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
48% more capital invested
Capital invested by funds: $1.68M → $2.48M (+$800K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
1.33% less ownership
Funds ownership: 7.08% → 5.75% (-1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$331K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.71K |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$571 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$35 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$370K |
| 2 |
Morgan Stanley
New York
|
-$3.11K |
| 3 |
Renaissance Technologies
New York
|
-$1.73K |
| 4 |
Citigroup
New York
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Adage Capital Partners
Boston,
Massachusetts
| $1.52M | – | – | – |
|
|
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $292K | +$331K | +38,253 | New |
|
|
3
Renaissance Technologies
New York
| $222K | -$1.73K | -200 | -0.7% |
|
4
BlackRock
New York
| $167K | – | – | – |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $152K | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $109K | +$39.9K | +4,617 | +42% |
|
|
HI
7
Hoey Investments
Coatesville,
Pennsylvania
| $8.24K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $5.53K | +$3.71K | +429 | +145% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $3.83K | – | – | – |
|
|
HI
10
Harbour Investments
Madison,
Wisconsin
| $504 | +$571 | +66 | New |
|
|
11
Wells Fargo
San Francisco,
California
| $107 | +$35 | +4 | +40% |
|
|
12
Morgan Stanley
New York
| $30 | -$3.11K | -360 | -99% |
|
|
RSCM
13
Rock Springs Capital Management
Baltimore,
Maryland
| – | -$370K | -80,033 | Closed |
|
|
14
Citigroup
New York
| – | -$5 | -1 | Closed |
|
CRVO Hedge Fund Activity: Q4 2023 in Review
12 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2023, worth a combined $2.48M — up 48% from $1.68M a quarter earlier.
Fund positioning in CRVO was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Carson Wealth (CWM LLC), opening a new position worth an estimated $331K. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $370K sold.
- 12 institutional investors held CervoMed (CRVO) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $2.48M of CervoMed stock for Q4 2023, up 48% quarter-over-quarter.
- 2 funds opened new CervoMed positions in Q4 2023 and 2 closed out, a net change of 0 holders.
- The largest CervoMed buyer in Q4 2023 was Carson Wealth (CWM LLC), an estimated $331K added.
- The largest CervoMed seller in Q4 2023 was Rock Springs Capital Management, an estimated $370K sold.
Based on aggregated 13F filings for Q4 2023.